Articles Published in 2010

Lambda acquires Biovail’s early phase unit

Tuesday, August 10, 2010 07:32 AM

As part of transforming from a maker of primarily generic drugs to a maker of innovator products, and also as part of its impending merger with Aliso Viejo, Calif.-based Valeant, Toronto-based Biovail has sold its 194-bed, phase I/bioanalystics lab to Indian CRO Lambda Therapeutic Research for $6 million.

More... »


Alzheimer’s Association launches TrialMatch

Monday, August 9, 2010 07:25 AM

In an effort to help fulfill an urgent need for clinical trials patients, the
Alzheimer’s Association has spent $1.2 million to create TrialMatch. Launched in mid-July, the phone and online system aims to match Alzheimer’s patients and their caregivers to ongoing clinical trials.

More... »


WuXi reports 2Q revenue growth after Charles River deal fails

Friday, August 6, 2010 08:45 AM

Shanghai-based WuXi PharmaTech will receive a breakup fee of $30 million from Charles River Laboratories International, whose previously announced purchase of Wuxi was terminated by mutual agreement due to Charles River shareholder opposition.

More... »

Quintiles relocates European HQ

Thursday, August 5, 2010 08:27 AM

Quintiles, a global contract research organization (CRO), announced that it is  relocating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading , England, overlooking the M4 motorway. 

More... »

CenterWatch Monthly August 2010

Wednesday, August 4, 2010 09:18 AM

Spike in Warning Letters Sends Tremors Through Industry

More... »

PPD, Microsoft help manage REMS programs

Wednesday, August 4, 2010 08:07 AM

PPD and Microsoft have entered into an agreement to jointly implement a technology solution designed to improve efficiency in managing U.S. Food and Drug Administration-mandated Risk Evaluation and Mitigation Strategy (REMS) programs.

More... »

Encorium Group acquires vaccine CRO

Tuesday, August 3, 2010 07:19 AM

Encorium Group has acquired Switzerland-based Progenitor International Research, a niche provider of drug development services in emerging regions, which allows the company to expand its vaccine development services into South America, India and Asia Pacific.

More... »

Duke puts PI on leave, suspends enrollment in three studies

Monday, August 2, 2010 08:16 AM

A high-profile principal investigator in oncology at Duke University has been placed on administrative leave while the university investigates whether he lied about Rhodes Scholar status on several grant applications. The university has also suspended patient enrollment in three trials he was involved in. 

More... »

QPS completes acquisition of Xendo

Friday, July 30, 2010 08:14 AM

QPS Holdings, a CRO providing testing services to support preclinical and clinical research and development, announced the completion of its acquisition of Xendo Drug Development (XDD), headquartered in Groningen, The Netherlands.

More... »

Bostwick in partnership with American International Biotechnology

Thursday, July 29, 2010 08:04 AM

Bostwick Scientific, the clinical trials division of Bostwick Laboratories, a global central anatomic pathology laboratory, announced a partnership with American International Biotechnology Services (AIBioTech.)

More... »

`

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs